Pardo, J.C.; Sanhueza, T.; Ruiz de Porras, V.; Etxaniz, O.; Rodriguez, H.; Martinez-Cardús, A.; Grande, E.; Castellano, D.; Climent, M.A.; Lobato, T.;
et al. Prognostic Impact of CD36 Immunohistochemical Expression in Patients with Muscle-Invasive Bladder Cancer Treated with Cystectomy and Adjuvant Chemotherapy. J. Clin. Med. 2022, 11, 497.
https://doi.org/10.3390/jcm11030497
AMA Style
Pardo JC, Sanhueza T, Ruiz de Porras V, Etxaniz O, Rodriguez H, Martinez-Cardús A, Grande E, Castellano D, Climent MA, Lobato T,
et al. Prognostic Impact of CD36 Immunohistochemical Expression in Patients with Muscle-Invasive Bladder Cancer Treated with Cystectomy and Adjuvant Chemotherapy. Journal of Clinical Medicine. 2022; 11(3):497.
https://doi.org/10.3390/jcm11030497
Chicago/Turabian Style
Pardo, Juan Carlos, Tamara Sanhueza, Vicenç Ruiz de Porras, Olatz Etxaniz, Helena Rodriguez, Anna Martinez-Cardús, Enrique Grande, Daniel Castellano, Miquel A. Climent, Tania Lobato,
and et al. 2022. "Prognostic Impact of CD36 Immunohistochemical Expression in Patients with Muscle-Invasive Bladder Cancer Treated with Cystectomy and Adjuvant Chemotherapy" Journal of Clinical Medicine 11, no. 3: 497.
https://doi.org/10.3390/jcm11030497
APA Style
Pardo, J. C., Sanhueza, T., Ruiz de Porras, V., Etxaniz, O., Rodriguez, H., Martinez-Cardús, A., Grande, E., Castellano, D., Climent, M. A., Lobato, T., Estudillo, L., Jordà , M., Carrato, C., & Font, A.
(2022). Prognostic Impact of CD36 Immunohistochemical Expression in Patients with Muscle-Invasive Bladder Cancer Treated with Cystectomy and Adjuvant Chemotherapy. Journal of Clinical Medicine, 11(3), 497.
https://doi.org/10.3390/jcm11030497
